Administering Shingrix previously required combining a lyophilised antigen with a liquid adjuvant from two separate vials.

The panel expressed concerns about the proposed doses of Blenrep (belantamab mafodotin) in GSK's marketing application, ...

GSK shares fell after a Food and Drug Administration advisory committee voted against approval of the company's Blenrep drug, a setback for its bid to reintroduce the blood-cancer treatment in the U.S ...

FDA advisers on Thursday voted against GSK's blood cancer drug Blenrep, finding that its risks outweighed its benefits at the ...

A setback for GSK after one of its late-stage pipeline assets failed to win the support of a US panel today triggered a 6% ...

Another week where the market has traded in a narrow range comes to an end today. The Nifty, so far, is down 38 points for ...

The jet maker said it has agreed to sell 12 of the aircraft to the airline, with options for six more. The British pharmaceutical company said combinations for its Blenrep drug were evaluated in ...

GSK shares sink after FDA panel rejects Blenrep cancer drug, raising doubts over turnaround strategy. GSK (LSE: GSK) investors took a sharp knock on Friday after its much-hyped blood cancer drug, ...

Euro US Dollar, US Dollar Japanese Yen, US Dollar Index Futures, United States 10-Year. Read 's Market Analysis on Investing.com UK.